Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcome Disparities in High-Grade Endometrial Cancer

Read full text Summarise with VIRAT
Authors: Charlie Chung, Brian Yueh, Santhilal Subhash, Onur Eskiocak, Aaron Nizam, Marissa G. Viola, Pascal Belleau, Ariel Kredentser, Arisa Kapedani, Alexander Krasnitz, Ken Simon, Werner Meier
+3 more Marina Frimer, Gary L. Goldberg, Semir Beyaz
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Organoid–NK cell coculture and autologous MMRp and MMRd organoid coculture validate our platform. A, Representative images of allogeneic NK cell coculture using a HGEC PDO line with or without IFNγ prestimulation. Red and green fluorescence represent HGEC PDOs and corresponding immune cells, respectively. Blue fluorescence represents active caspase 3 signals. Scale bar, 70 μm. B, Colocalization of PDOs and immune cells over the time of imaging. The area under the curve was used for statistical significance (ordinary t test). C, The end point viability of PDOs in the coculture measured by colocalization coefficient between organoid and caspase-3 signals. D, Representative images of coculture using MMRd and MMRp HGEC PDOs and autologous PBMCs. Scale bar, 70 μm. E, Quantification of MHC-I, -II, and PD-L1 protein expression levels of the MMRd and MMRp HGEC PDO lines measured by flow cytometry. MFI, mean fluorescent intensity. F, Colocalization of PDOs and immune cells at 14 hours of coculture period. G, Viability of the MMRd PDO in the coculture measured by colocalization coefficient between organoid and caspase-3 signals at 12 and 20 hours coculture period. H, Viability of the MMRp PDO in the coculture measured by colocalization coefficient between organoid and caspase-3 signals at 12 and 20 hours coculture period. Cas3, caspase-3. Ordinary one-way ANOVA (C, G, and H) and t test (F) were used to calculate statistical significance (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immune Cell Function and Interaction Immunotherapy and Immune Responses

Publication details

Publication date
25 March 2026
Language
EN